3 months of romosozumab: a pragmatic clinical solution

Key Points

• Romosozumab treatment improves bone density in individuals with osteoporosis, enhancing their bone health.
• Patients undergoing a three-month regimen of romosozumab saw significant improvements in bone metrics.
• This observational analysis assesses the effectiveness of romosozumab as a treatment for osteoporosis over three months.
• The findings indicate that romosozumab could be a promising therapeutic option, supporting further research.